# Impact of Morphine Treatment on Platelet Inhibition in Acute Myocardial Infarction

> **NCT02627950** · PHASE4 · COMPLETED · sponsor: **University of Luebeck** · enrollment: 138 (actual)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

- **DRUG:** Morphinhydrochloricum
- **DRUG:** Metoclopramide
- **DRUG:** Ticagrelor
- **DRUG:** Isotonic sodium chloride

## Key facts

- **NCT ID:** NCT02627950
- **Lead sponsor:** University of Luebeck
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2018-10
- **Final completion:** 2018-10
- **Target enrollment:** 138 (ACTUAL)
- **Last updated:** 2019-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02627950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02627950, "Impact of Morphine Treatment on Platelet Inhibition in Acute Myocardial Infarction". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02627950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*